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background:  Evidence for multivessel (MV) revascularization in cardiogenic shock (CS) and multivessel disease (MVD) is still not 
enough. We compared outcomes following MV or culprit vessel (CV) revascularizations performed at the time of primary percutaneous 
coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients with CS and MVD.
methods:  From 16,620 STEMI patients who underwent primary PCI in a nationwide, prospective, multicenter registry between January 
2006 and December 2012, eligible 510 patients with CS and MVD were selected and divided into MV (n=124, 24.3%) and CV (n=386, 
75.7%) revascularization groups. The primary outcomes were in-hospital mortality and all-cause death during follow-up. A weighted Cox 
regression model was constructed using the inverse probability of treatment weighting to compare hazard rates of outcomes between the 
two groups.
Results:  Compared to CV revascularization, MV revascularization had a significantly lower risk of in-hospital mortality (hazard ratio[HR] 
0.263, 95% confidence interval[CI] 0.149-0.462, p<0.001) and all-cause death (HR 0.400, 95% CI 0.264-0.606, p<0.001), mainly due 
to lower cardiac death (HR 0.510, 95% CI 0.329-0.790, p=0.002). In addition, MV revascularization significantly decreased the risk of 
composite of all-cause death, recurrent myocardial infarction, and any revascularization (HR 0.728, 95% CI 0.55-0.965, p=0.027) during 
follow-up period.
conclusion:  This study showed that, compared to CV revascularization, MV revascularization at the time of primary PCI was associated 
with improved outcomes in STEMI patients with CS and MVD. Our results support the current guidelines of American College of 
Cardiology/American Heart Association on revascularizations in STEMI with CS and MVD.
